News from neurocrine biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 03, 2015, 13:00 ET

Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference Live Audio Webcast Will be on March 10, 2015

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Feb 24, 2015, 13:00 ET

Neurocrine Biosciences to Present at Cowen and Company's 35th Annual Health Care Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Feb 20, 2015, 07:00 ET

Neurocrine Biosciences, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the underwriters of its previously announced public offering have exercised in...

Feb 19, 2015, 07:00 ET

Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the pricing of its underwritten public offering of 6,944,000 shares of its common stock...

Feb 17, 2015, 16:08 ET

Neurocrine Biosciences, Inc. Announces Proposed Public Offering of $225 Million of Common Stock

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it has commenced an underwritten public offering of shares of its common stock to...

Feb 09, 2015, 16:01 ET

Neurocrine Biosciences Reports Year-End 2014 Results and Provides Investor Update for 2015

 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter and year ended December 31, 2014. For the...

Feb 04, 2015, 13:00 ET

Neurocrine Biosciences to Present at the 2015 Leerink Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin, Chief Financial Officer of Neurocrine Biosciences, will be...

Feb 02, 2015, 13:00 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2014 Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its fourth quarter and year-end 2014 results after the...

Jan 20, 2015, 08:00 ET

Neurocrine Biosciences Announces Oral Presentation of NBI-77860 Clinical Trial Data in Classic Congenital Adrenal Hyperplasia at ENDO 2015

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the steering committee of ENDO 2015 has selected the abstract of their recently...

Jan 16, 2015, 14:30 ET

Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI-77860 in Congenital Adrenal Hyperplasia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor...

Jan 08, 2015, 13:00 ET

Neurocrine Biosciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will...

Dec 10, 2014, 08:00 ET

Neurocrine Biosciences Announces Expansion of its Clinical Pipeline

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor...

Dec 04, 2014, 19:00 ET

Neurocrine Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Nov 25, 2014, 13:00 ET

Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Nov 12, 2014, 13:56 ET

Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Nov 04, 2014, 07:30 ET

Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that Darin Lippoldt has joined the executive management team as Chief Legal...

Nov 03, 2014, 19:00 ET

Neurocrine Biosciences to Present at the Nomura Biotechnology Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Nov 03, 2014, 16:01 ET

Neurocrine Biosciences Reports Third Quarter 2014 Results

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended September 30, 2014.  For the third...

Oct 30, 2014, 07:30 ET

Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...

Oct 27, 2014, 16:05 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2014 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its third quarter 2014 financial results after the Nasdaq...